Assessing the validity of current mouse genetic models of obsessive-compulsive disorder - PubMed (original) (raw)
Review
Assessing the validity of current mouse genetic models of obsessive-compulsive disorder
Li Wang et al. Behav Pharmacol. 2009 Mar.
Abstract
Obsessive-compulsive disorder (OCD) is a disorder characterized by unwanted and intrusive thoughts, images, or impulses and/or repetitive behavior. OCD is a major cause of disability; however, the genetic factors and pathophysiological mechanisms underlying this complex, heterogeneous disorder remain largely unknown. During the past decade, a number of putative mouse genetic models of OCD have been developed for the purpose of studying the neural mechanisms underlying this disorder and developing novel treatments. This review presents and evaluates these experimental preparations to date. Models using knockout or transgenic approaches, as well as those examining variation in genetically diverse populations, are evaluated and discussed.
Conflict of interest statement
All authors declare that there are no personal financial holdings that could be perceived as constituting a potential conflict of interest.
Similar articles
- Molecular and cellular basis of obsessive-compulsive disorder-like behaviors: emerging view from mouse models.
Yang XW, Lu XH. Yang XW, et al. Curr Opin Neurol. 2011 Apr;24(2):114-8. doi: 10.1097/WCO.0b013e32834451fb. Curr Opin Neurol. 2011. PMID: 21386675 Review. - Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges.
Wolmarans W, Scheepers IM, Stein DJ, Harvey BH. Wolmarans W, et al. Metab Brain Dis. 2018 Apr;33(2):443-455. doi: 10.1007/s11011-017-0161-7. Epub 2017 Dec 6. Metab Brain Dis. 2018. PMID: 29214602 Review. - A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.
Grados M, Prazak M, Saif A, Halls A. Grados M, et al. Expert Opin Drug Discov. 2016;11(1):27-43. doi: 10.1517/17460441.2016.1103225. Epub 2015 Nov 11. Expert Opin Drug Discov. 2016. PMID: 26558411 Review. - Genetic susceptibility in obsessive-compulsive disorder.
Fernandez TV, Leckman JF, Pittenger C. Fernandez TV, et al. Handb Clin Neurol. 2018;148:767-781. doi: 10.1016/B978-0-444-64076-5.00049-1. Handb Clin Neurol. 2018. PMID: 29478613 Review. - [Pathophysiological bases of obsessive-compulsive disorder and therapeutic implications].
Aouizerate B. Aouizerate B. Rev Prat. 2007 Jan 15;57(1):59-63. Rev Prat. 2007. PMID: 17432003 Review. French.
Cited by
- Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice.
Aida T, Yoshida J, Nomura M, Tanimura A, Iino Y, Soma M, Bai N, Ito Y, Cui W, Aizawa H, Yanagisawa M, Nagai T, Takata N, Tanaka KF, Takayanagi R, Kano M, Götz M, Hirase H, Tanaka K. Aida T, et al. Neuropsychopharmacology. 2015 Jun;40(7):1569-79. doi: 10.1038/npp.2015.26. Epub 2015 Feb 9. Neuropsychopharmacology. 2015. PMID: 25662838 Free PMC article. - Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.
Hunsaker MR. Hunsaker MR. Prog Neurobiol. 2012 Feb;96(2):220-41. doi: 10.1016/j.pneurobio.2011.12.001. Epub 2012 Jan 13. Prog Neurobiol. 2012. PMID: 22266125 Free PMC article. Review. - Dopaminergic control of cognitive flexibility in humans and animals.
Klanker M, Feenstra M, Denys D. Klanker M, et al. Front Neurosci. 2013 Nov 5;7:201. doi: 10.3389/fnins.2013.00201. Front Neurosci. 2013. PMID: 24204329 Free PMC article. Review. - Slitrks as emerging candidate genes involved in neuropsychiatric disorders.
Proenca CC, Gao KP, Shmelkov SV, Rafii S, Lee FS. Proenca CC, et al. Trends Neurosci. 2011 Mar;34(3):143-53. doi: 10.1016/j.tins.2011.01.001. Trends Neurosci. 2011. PMID: 21315458 Free PMC article. Review. - Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics.
Ting JT, Feng G. Ting JT, et al. Curr Opin Neurobiol. 2011 Dec;21(6):842-8. doi: 10.1016/j.conb.2011.04.010. Epub 2011 May 24. Curr Opin Neurobiol. 2011. PMID: 21605970 Free PMC article. Review.
References
- Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, et al. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol. 2005;8:391–401. - PubMed
- Albert U, Aguglia E, Maina G, Bogetto F. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. J Clin Psychiatry. 2002;63:1004–1009. - PubMed
- Alonso P, Gratacos M, Menchon JM, Saiz-Ruiz J, Segalas C, Baca-Garcia E, et al. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Biol Psychiatry. 2008;63:619–628. - PubMed
- Alsobrook JP, II, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet. 2002;114:116–120. - PubMed
Publication types
MeSH terms
Grants and funding
- 5K01MH071555/MH/NIMH NIH HHS/United States
- 1R24MH080022/MH/NIMH NIH HHS/United States
- K24 MH091555/MH/NIMH NIH HHS/United States
- K01 MH071555/MH/NIMH NIH HHS/United States
- R24 MH080022-02/MH/NIMH NIH HHS/United States
- 5R01MH079424/MH/NIMH NIH HHS/United States
- R24 MH080022/MH/NIMH NIH HHS/United States
- R01 MH079424-03/MH/NIMH NIH HHS/United States
- R01 MH079424/MH/NIMH NIH HHS/United States
- K01 MH071555-04/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous